Scynexis SCYX
NASDAQ SCYX
$5.16 +0.01 (+0.10%)
At close: Aug 20, 2026 · 10:50 AM UTC

Scynexis (SCYX) Gross Profit (2013 - 2024)

Scynexis' (SCYX) quarterly Gross Profit came in at $977000.0 in Q4 2024, up 110.99% YoY from $463047.3 in Q1 2024, and up 48.03% on a QoQ basis from $660000.0 in Q3 2024.

Scynexis (SCYX) Gross Profit (2013 - 2024) Analysis & Trends

Scynexis (SCYX) has 7 years of Gross Profit data on file, last reported at $977000.0 in Q4 2024.

  • Quarterly Gross Profit rose 110.99% year-over-year to $977000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.7 million (down 96.99% YoY) and the FY2024 annual result came in at $3.7 million, down 96.99% from the prior year.
  • Gross Profit grew to $977000.0 in Q4 2024, from $660000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $131.0 million in Q2 2023 to a low of -$8.9 million in Q4 2023.
  • A 4-year average of $9.7 million and a median of $993000.0 in 2023 frame the typical range for Gross Profit.
  • The widest YoY moves for Gross Profit: up 11013.49% in 2023, down 769.2% in 2023.
  • Tracing SCYX's Gross Profit over 4 years: stood at $430000.0 in 2021, then jumped by 208.84% to $1.3 million in 2022, then plunged by 769.2% to -$8.9 million in 2023, then soared by 110.99% to $977000.0 in 2024.
  • The last three Gross Profit figures came in at $977000.0 (Q4 2024), $660000.0 (Q3 2024), and $736000.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.76 Bn 42.79 Bn -
2 Teva Pharmaceutical Industries 43.38 Bn 39.73 Bn 2.15 Bn
3 Zoetis 31.61 Bn 29.93 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.64 Bn 22.84 Bn 5.10 Bn
5 United Therapeutics 22.20 Bn 19.54 Bn 683.80 Mn
6 Viatris 18.82 Bn 17.93 Bn 1.46 Bn
7 Neurocrine Biosciences 15.67 Bn 15.28 Bn 935.80 Mn
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn -
10 Scynexis 60.95 Mn -53.74 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 977,000.00
Dec 31, 2024 977,000.00
Sep 30, 2024 660,000.00
Sep 30, 2024 660,000.00
Jun 30, 2024 736,000.00
Jun 30, 2024 736,000.00
Mar 31, 2024 1.37 Mn
Mar 31, 2024 1.37 Mn
Dec 31, 2023 -8.89 Mn
Dec 31, 2023 -8.89 Mn
Sep 30, 2023 1.38 Mn
Sep 30, 2023 1.38 Mn
Jun 30, 2023 131.03 Mn
Jun 30, 2023 131.03 Mn
Mar 31, 2023 993,000.00
Mar 31, 2023 993,000.00
Dec 31, 2022 1.33 Mn
Dec 31, 2022 1.33 Mn
Sep 30, 2022 1.37 Mn
Sep 30, 2022 1.37 Mn